- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Turkish agrochemical industry drives for Europe
?
Dr Murat Kantarci, general secretary of the Turkish crop protection association (ZIMID), talks to Robert Birkett about the dynamics of the Turkish agrochemical industry.
Turkey’s agrochemical market supplies strong evidence to back the cliché of Turkey lying at the crossroads of Europe and Asia. Agriculture dominates in the country, and Turkish companies make up around half of the national agrochemical market, general secretary of the Turkish crop protection association (ZIMID) Dr Murat Kantarci says. But the industry is preparing for change and looking west to the EU.
Half of the companies in the pesticide market’s top ten and two of the top five were Turkish in 2007, ZIMID’s indicative figures suggest. The second-largest company in the market and Turkey’s major pesticide company was Hektas. It had a 21% share of the agrochemical market. There were three companies with over 10% of the market. The others were Bayer CropScience as the largest, accounting for 22% of the market, and Syngenta (18%). Other key Turkish companies included Koruma, Safa and Dogal. Turkey is a country of strong agricultural traditions and more than one in four Turks (27%) work in agriculture. It accounts for roughly 10% of the Turkish economy.
“There are 300 registered pesticide importers, although recently around 130-140 have been active,” Dr Kantarci says. “The structure of the Turkish CPP [crop protection product] market is different to that of major European markets, for example.”
Dr Kantarci notes the large share of generic products on the national market, “due to quite low requirements for me-too registrations”. Prices also tend to be lower than in Europe, he says. That impacts on suppliers’ profitability and the opportunity to launch innovations onto the market, the ZIMID chief adds. “In extreme cases, [innovative products] are delayed or not launched as they would be uncompetitive against alternative generic products.”
Dr Kantarci
文档评论(0)